FibroGen Reports First Quarter 2017 Financial Results
May 09, 2017 20:05 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided an update on the company’s recent...
FibroGen Reports First Quarter 2017 Financial Results
May 09, 2017 20:05 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided an update on the company’s recent...
FibroGen Reports First Quarter 2017 Financial Results
May 09, 2017 20:05 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided an update on the company’s recent...
Blue Buffalo Reports First Quarter 2017 Results
May 09, 2017 20:05 pm UTC| Business
WILTON, Conn., May 09, 2017 -- Blue Buffalo Pet Products, Inc. (the “Company”) (NASDAQ:BUFF), the leading natural pet food company in the United States, today announced its first quarter 2017 results. First Quarter...
Blue Buffalo Reports First Quarter 2017 Results
May 09, 2017 20:05 pm UTC| Business
WILTON, Conn., May 09, 2017 -- Blue Buffalo Pet Products, Inc. (the “Company”) (NASDAQ:BUFF), the leading natural pet food company in the United States, today announced its first quarter 2017 results. First Quarter...
Blue Buffalo Reports First Quarter 2017 Results
May 09, 2017 20:05 pm UTC| Business
WILTON, Conn., May 09, 2017 -- Blue Buffalo Pet Products, Inc. (the “Company”) (NASDAQ:BUFF), the leading natural pet food company in the United States, today announced its first quarter 2017 results. First Quarter...
MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress
May 09, 2017 20:05 pm UTC| Business
Company to Host Conference Call and Webcast Today at 2:00 PM PT (5:00 PM ET) SOUTH SAN FRANCISCO, Calif., May 09, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a...